Showing 147,021 - 147,040 results of 229,664 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 10 ((we decrease) OR (a decrease)) ))', query time: 1.61s Refine Results
  1. 147021
  2. 147022
  3. 147023
  4. 147024
  5. 147025
  6. 147026
  7. 147027
  8. 147028
  9. 147029
  10. 147030
  11. 147031

    SPARC-mediated SLUG expression and promotion of melanoma cell migration is PI3K/AKT dependent. by Nina Fenouille (149658)

    Published 2012
    “…Immunoblots show the phosphorylation status of MAP kinases ERK and AKT and expression levels of SLUG. HSP60 was used as a loading control. (<b>B</b>) <i>Influence of PI3K/AKT signaling on cell migration:</i> serum-stimulated cell migration was analyzed using Boyden chamber assays in control and SPARC 501mel cells treated with DMSO or 10 mmol/L AIIV or LY294002 as indicated. …”
  12. 147032

    DataSheet1_Circadian Strain, Light Exposure, and Depressive Symptoms in Rural Communities of Southern Brazil.pdf by Luísa K. Pilz (5648060)

    Published 2022
    “…Our results suggest that low light exposure during the day, and higher levels of SJL are associated with depressive symptoms; longitudinal and experimental studies are needed to understand the underlying mechanisms. Nevertheless, we highlight the potential of treatment strategies aimed at decreasing circadian strain and insufficient light exposure, which are suggested as areas of further research in Psychiatry.…”
  13. 147033
  14. 147034
  15. 147035
  16. 147036
  17. 147037

    Arrest and synchronous triggering of ASLV pseudovirus fusion with endosomes using NH<sub>4</sub>Cl. by Sergi Padilla-Parra (166100)

    Published 2012
    “…S1</a> and <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1002694#ppat.1002694.s002" target="_blank">S2</a>). …”
  18. 147038

    Table_3_Comprehensive Analysis of NAFLD and the Therapeutic Target Identified.XLS by Weiheng Wen (5714254)

    Published 2021
    “…The five candidate therapeutic targets were ENO3, CXCL10, INHBE, LRRC31, and OPTN. Moreover, the efficiency of hepatocyte adipogenesis decreased after OPTN knockout, confirming the potential use of OPTN as a new therapeutic target for NAFLD.…”
  19. 147039

    Table_2_Comprehensive Analysis of NAFLD and the Therapeutic Target Identified.XLS by Weiheng Wen (5714254)

    Published 2021
    “…The five candidate therapeutic targets were ENO3, CXCL10, INHBE, LRRC31, and OPTN. Moreover, the efficiency of hepatocyte adipogenesis decreased after OPTN knockout, confirming the potential use of OPTN as a new therapeutic target for NAFLD.…”
  20. 147040

    Image_1_Comprehensive Analysis of NAFLD and the Therapeutic Target Identified.JPEG by Weiheng Wen (5714254)

    Published 2021
    “…The five candidate therapeutic targets were ENO3, CXCL10, INHBE, LRRC31, and OPTN. Moreover, the efficiency of hepatocyte adipogenesis decreased after OPTN knockout, confirming the potential use of OPTN as a new therapeutic target for NAFLD.…”